Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: A phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study

Journal of Drugs in Dermatology

Volumn 10, Issue 12, 2011, Pages 1382-1396

  Eichenfielda, Lawrence F ^a   Alió Sáenz, Alessandra B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE PLUS CLINDAMYCIN;

ACNE; ACNE VULGARIS; ADOLESCENT; ADULT; APPLICATION SITE DERMATITIS; APPLICATION SITE DRYNESS; APPLICATION SITE ECZEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE PHOTOSENSITIVITY REACTION; APPLICATION SITE PRURITUS; APPLICATION SITE RASH; ARTICLE; CHILD; CONTACT DERMATITIS; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN DEFECT; SKIN INFLAMMATION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BELIZE; BENZOYL PEROXIDE; CANADA; CHILD; CLINDAMYCIN; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84055190667     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hanna S, Sharma J, Klotz J. Acne vulgaris: More than skin deep. Dermatol Online J. 2003;9:8.
2. Bergfeld WF. The pathophysiology of acne vulgaris in children and adolescents, part 2: Tailoring treatment. Cutis. 2004;74:189-192. (Pubitemid 39330123)
3. Ozolins M, Eady EA, Avery A, et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol Assess. 2005;9:iii-212.
4. Koreck A, Pivarcsi A, Dobozy A, Kemeny L. The role of innate immunity in the pathogenesis of acne. Dermatology. 2003;206:96-105. (Pubitemid 36205274)
5. Zaenglein AL. Topical retinoids in the treatment of acne vulgaris. Semin Cutan Med Surg. 2008;27:177-182.
6. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206:37-53. (Pubitemid 36164665)
7. Feneran AN, Kaufman WS, Dabade TS, Feldman SR. Retinoid plus antimicrobial combination treatments for acne. Clin Cosmet Investig Dermatol. 2011;4:79-92.
8. Webster GF. Evidence-based review: Fixed-combination therapy and topical retinoids in the treatment of acne. J Drugs Dermatol. 2011;10:636-644.
9. Tucker R, Walton S. The role of benzoyl peroxide in the management of acne vulgaris. Pharm J. 2007;279:48-53. (Pubitemid 47162496)
10. Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: A review of its use in the management of acne. Am J Clin Dermatol. 2002;3:349-360. (Pubitemid 34753688)
11. Dhawan SS. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Cutis. 2009;83:265-272.
12. Ellis CN, Leyden J, Katz HI, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis. 2001;67:13-20.
13. Gold MH. A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne. J Clin Aesthet Dermatol. 2009;2:44-48.
14. Webster G, Rich P, Gold MH, et al. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations. J Drugs Dermatol. 2009;8:736-743.
15. Thiboutot D, Zaenglein A, Weiss J, et al. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol. 2008;59:792-800.